These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 484171)

  • 1. Investigation of cholecystokinin-octapeptide splitting enzyme in dog kidney.
    Lonovics J; Hajnal F; Mara P; Szabó I; Varró V
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):222-6. PubMed ID: 484171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-destroying activities of canine tissue homogenates.
    Lonovics J; Penke B; Rayford PL; Thompson JC
    Hepatogastroenterology; 1986 Feb; 33(1):27-33. PubMed ID: 3082732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action.
    Behar J; Biancani P
    J Clin Invest; 1980 Dec; 66(6):1231-9. PubMed ID: 7440712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
    Regan PT; Go VL; DiMagno EP
    J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog.
    Meyer FD; Gyr K; Häcki WH; Beglinger C; Jeker L; Varga L; Kayasseh L; Gillessen D; Stalder GA
    Gastroenterology; 1981 Apr; 80(4):742-7. PubMed ID: 7202946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Distribution of renal kininases in relation to the kallikrein-bradykinin system and water excretion.
    Ward PE; Mills IH
    J Endocrinol; 1975 Nov; 67(2):60P. PubMed ID: 173783
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of gastric emptying is a physiological action of cholecystokinin.
    Debas HT; Farooq O; Grossman MI
    Gastroenterology; 1975 May; 68(5 Pt 1):1211-7. PubMed ID: 1126597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease.
    Doty JE; Pitt HA; Porter-Fink V; Denbesten L
    Ann Surg; 1985 Jan; 201(1):76-80. PubMed ID: 3917658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholecystokinin-octapeptide on lower esophageal sphincter.
    Behar J; Biancani P
    Gastroenterology; 1977 Jul; 73(1):57-61. PubMed ID: 863201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of cholecystokinin octapeptide on smooth muscles of stomach, ileum and gall bladder.
    Rakovska A; Milenov K; Yanev S
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):697-703. PubMed ID: 3807471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine model for clear-cut study on the role of cholecystokinin in antral, small intestinal and gallbladder motility.
    Romański KW
    Pol J Pharmacol; 2004; 56(2):247-56. PubMed ID: 15156076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of cholecystokinin-octapeptide on sphincter of Oddi basal pressure and phasic wave activity in humans.
    Toouli J; Hogan WJ; Geenen JE; Dodds WJ; Arndorfer RC
    Surgery; 1982 Sep; 92(3):497-503. PubMed ID: 6287657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of captopril and reserpine on the activity of certain neuropeptide metabolism enzymes].
    Gengin MT; Vernigora AN; Nikishin NN; Makeeva NV
    Vopr Med Khim; 1995; 41(5):37-9. PubMed ID: 8553625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
    Romański KW
    J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat.
    Gillis RA; Quest JA; Pagani FD; Souza JD; Da Silva AM; Jensen RT; Garvey TQ; Hamosh P
    J Pharmacol Exp Ther; 1983 Feb; 224(2):408-14. PubMed ID: 6296361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duodenum is important for the sphincter of Oddi motor response to cholecystokinin octapeptide in conscious dogs.
    Dong M; Sonoda Y; Kawamoto M; Konomi H; Kobayashi K; Yamaguchi K; Tanaka M
    J Gastroenterol; 2005 Apr; 40(4):389-95. PubMed ID: 15870975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of inhibition of pancreatic secretion by isoproterenol.
    Kelly GA; Rose RC; Nahrwold DL
    Surgery; 1977 Nov; 82(5):680-4. PubMed ID: 918855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.
    Johnson LR; Guthrie P
    Gastroenterology; 1976 Jan; 70(1):59-65. PubMed ID: 1245285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.